Biosensors Market with COVID-19 Impact by Type, Product (Wearable, Non-wearable), Technology, Application (POC, Home Diagnostics, Research Lab, Environmental Monitoring, Food & Beverages, Biodefense) and Region - Global Forecast to 2026
[228 Pages Report] The biosensors market is valued at USD 25.5 billion in 2021 and is projected to reach USD 36.7 billion by 2026; it is expected to grow at a CAGR of 7.5% from 2021 to 2026.
Some of the key driving factors of the biosensors market are the emergence of nanotechnology-based biosensors, significant technological advancements in the last few years, increasing use of biosensors to monitor glucose levels in individuals with diabetes, surging demand for home-based point of care devices due to the COVID-19 pandemic, and rising government initiatives toward diagnostics
To know about the assumptions considered for the study, Request for Free Sample Report
Biosensors market
The biosensors market includes major Tier I and II players like Abbott (US), Roche (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), DuPont (US), and others.
Biosensors marketDynamics
Driver: Emergence of nanotechnology-based biosensors
Nanotechnology-based biosensors are made up of nanomaterials and have dimensions ranging from 1 to 100 nm. These biosensors play a vital role in sensing the mechanism of biosensing technology. Integrating devices of nanomaterials with electrical systems has led to the development of nanoelectromechanical systems. Several nanomaterials have been explored for electronic and mechanical properties for use in improving biological signaling and transduction mechanism, which involves the conversion of one form of energy to another. A few such materials that are widely employed include nanotubes, nanowires, nanorods, nanoparticles, and thin films made up of crystalline matter. These sensors can be used in applications ranging from amperometric devices for the enzymatic detection of glucose to the use of quantum dots as fluorescence agents for the detection of binding and bio-conjugated nanomaterials for biomolecular detection
Restraint: Slow rate of commercialization and reluctance in adopting new treatment practices
Biosensors technology has witnessed a slow rate of commercialization in recent years due to the high price of biosensors and the demand emanating only from the healthcare industry. Commercializing biosensors for nonmedical applications, such as military, biodefense, fermentation control, and environment monitoring is a challenge for industry players due to limited R&D and positive outcomes. The biosensors market is also witnessing slow commercialization, primarily due to price sensitivity; acceptance from end users; and concerns related to the quality, authenticity, and reliability of the products.
Opportunity: High-growth opportunities in the wearable device market
Wearable biosensors find increasing opportunities for the continuous monitoring of vital signs of patients, premature infants, children, athletes or fitness buffs, and individuals in remote areas far from medical and health services. Wearable and connected biosensors enable remote monitoring to allow patients to avoid hospitalization or leave earlier. By enabling telemedicine (monitoring and transmitting physiological data from outside the hospital), wearable biosensors can ease the burden on healthcare personnel and free up hospital space for more responsive care. Smart textiles with sensors in the fabric can provide a simple, more convenient system to monitor vital signs. Biosensor patches or tattoos, leverage conformal, printed electronics, can better enable physicians to collect data on a patient for long periods. Such sensors dovetail with the quantified self-trend to track one’s biological data to optimize one’s health. Moreover, disposable patches can allow analyzing key biomarkers such as sodium, potassium, and glucose, in sweat or other substances.
Challenge: Government regulations—long certification and approval cycles
Despite the high demand for biosensors for medical applications, manufacturers are facing several regulatory barriers due to multilayered regulations mandated by the FDA and the laboratory regulations under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) (for the premarket approval of POC testing kits). For the approval of any new POC device in the US, manufacturers are required to submit performance data to the FDA. This data should demonstrate that healthcare professionals and patients can use devices and can obtain results like clinical laboratory tests.
Embedded device segment of biosensors market to hold highest market share during the forecast period
Based on type, embedded devices hold a larger market share of the biosensors market. These devices are widely used across a range of applications such as point of care, home diagnostics, food & beverages, research lab, environmental monitoring, and biodefense. With the proliferation of the Internet of Things (IoT) devices, there has been a huge transformation in terms of connected healthcare applications. IoT enables real-time alerting, tracking, and monitoring, which permits hands-on treatments, better accuracy, appropriate intervention by doctors, and improved complete patient care. Many healthcare facilities have started adopting embedded solutions for medical devices enabled with IoT to address the lack of availability of doctors in remote areas. These IoT-enabled medical devices help identify diseases in patients and conduct different tests to provide accurate and reliable treatment to patients in remote locations. Therefore, the rising adoption of embedded devices will drive the market growth of biosensors.
Wearable biosensors to hold the highest CAGR in the biosensors market from 2021 to 2026
Wearable biosensors have attracted considerable attention because of their potential to change classical medical diagnostics and continuous health monitoring concepts. Wearable biosensor applications aim to change centralized hospital-based care systems to home-based personal medicine and reduce healthcare cost and time for diagnosis. Nowadays, we can see that wearable biosensors are bringing out a wave of innovation to society. Their comfort and better use can provide a new level of exposure to a patient’s real-time health status. This real-time data availability allows better clinical decisions and results in better health results and more efficient use of health systems. For human society, wearable biosensors may help in the early detection of health events and the avoidance of hospitalization. Such events are expected to boost the market growth of wearable biosensors.
Electrochemical technology segment to hold highest market share during the forecast period
Based on technology, the biosensors market for electrochemical technology holds the largest share during the forecast period. Electrochemical biosensors are increasingly used in non-medical applications, such as environmental monitoring; and are also used in the quality control of food and beverages. The most common type of electrochemical biosensor is the glucose sensor, which is currently used across point of care and home diagnostic applications. Indirect monitoring through electrochemical biosensors can be done to analyze organic pesticides or inorganic substances that interfere with the biocatalytic properties of the sensor. This involves the monitoring of heavy metals, fluoride, cyanide, and others that have high importance in industries and environments.
Biosensors market across home diagnostic application to grow at the highest rate from 2021 to 2026
The market for home diagnostics applications is expected to grow at the highest rate during the forecast period. The market growth can be attributed to increasing developments in the healthcare sector, the high rate of adoption of new diagnostic methods, and convenience in terms of using home-based medical devices. The novel coronavirus outbreak has led to an increase in demand for home diagnostics. Hence, manufacturers in the home diagnostics market are expanding their production capacities. Moreover, there is an increased demand across the wearable devices segment, and as lifestyle diseases become more prevalent, there is huge potential for the biosensors market across the home diagnostics segment.
Biosensors market in APAC to grow at the highest rate from 2021 to 2026
APAC is expected to experience the highest growth rate in the biosensors market, during the forecast period. The presence of a large population base and increasing incidents of different lifestyle diseases are the main factors for the growth of the market in APAC. In terms of foreign investments, the healthcare industry in China has been steadily opening to foreign participation, both in terms of removal of items in the National Negative List, and the addition of items on the National Encouraged List. In 2019, new raw materials for the production of vaccines and medical institutions were newly added to the 2019 National Encouraged List. This indicates that China is now encouraging investments across the healthcare sector and unlocking opportunities for foreign investors to access preferential policies and tax rates. Such policies are expected to attract several opportunities for the biosensors market in APAC.
To know about the assumptions considered for the study, download the pdf brochure
Key Market Players
The Biosensors market is dominated by players such as Abbott (US), Roche (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), and DuPont (US).
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market size available for years |
2017-2026 |
|
Base year considered |
2017 |
|
Forecast period |
2021-2026 |
|
Forecast units |
Value (USD Million/Billion) |
|
Segments covered |
By Type, By Product, By Technology, By Application |
|
Geographies covered |
North America, Europe, APAC, and RoW |
|
Companies covered |
The major market players Abbott (US), Roche (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), DuPont (US), Biosensors International Group, Ltd. (Singapore), Cytiva (UK), Dexcom, Inc. (US), Lifescan IP Holdings, LLC (US), Masimo (US), Nova Biomedical (US), and Universal Biosensors (Australia) (Total 25 players are profiled) |
The study categorizes the biosensors market based on type, product, technology, and application at the regional and global level.
Biosensors market, By Type
- Sensor Patch
- Embedded Device
Biosensors market, By Product
- Wearable Biosensors
- Non-wearable Biosensors
Biosensors market, By Technology
- Electrochemical Biosensors
- Optical Biosensors
- Piezoelectric Biosensors
- Thermal Biosensors
- Nanomechanical Biosensors
Biosensors market, By Application
- POC
- Home Diagnostics
- Research Labs
- Environmental Monitoring
- Food & Beverages
- Biodefense
Biosensors market, By Region
- North America
- Europe
- APAC
- RoW
Recent Developments
- In January 2021, Roche signed a Global Business Partnership Agreement (GBP) with Sysmex to deliver hematology testing solutions. The new agreement aims to utilize the IT systems to lead to improved clinical decision-making and customer experience. This successful, long-running partnership continues to evolve and bring hematology testing innovations to laboratories globally.
- In December 2020, Abbott announced its next-generation, sensor-based glucose monitoring technology, FreeStyle Libre 2, which received approval by Health Canada for adults and children (4 years and older) with diabetes.
- In December 2020, Bio-Rad Laboratories announced the expansion of its joint marketing agreement with Siemens Healthineers, in which Bio-Rad will provide quality control products and Unity Quality Control data management solutions for Siemens Healthineers’ Atellica Solution platforms.
- In November 2020, Medtronic launched InPen integrated with real-time Guardian Connect CGM data. InPen is the first and only FDA-cleared smart insulin pen on the market for people on multiple daily injections (MDI).
- In October 2020, Bio-Rad Laboratories announced the global launch of its CFX Opus 96 and CFX Opus 384 Real-time PCR Systems, along with BR.io, a cloud-based instrument connectivity, data management, and analysis platform.
- In September 2020, Medtronic received US Food and Drug Administration (FDA) approval of its MiniMed 770G hybrid closed loop system. This newest insulin pump system offers the company’s most advanced SmartGuard technology, as featured in the MiniMed 670G system, with the added benefits of smartphone connectivity and an expanded age indication down to the age of 2 years old.
- In June 2020, Abbott and Tandem Diabetes Care finalized an agreement to develop and commercialize integrated diabetes solutions that combine Abbott's world-leading continuous glucose monitoring (CGM) technology with Tandem's innovative insulin delivery systems to provide more options for people to manage their diabetes.
Frequently Asked Questions (FAQ):
What is the market size for the biosensors market?
The biosensors market is valued at USD 25.5 billion in 2021 and is projected to reach USD 36.7 billion by 2026; it is expected to grow at a CAGR of 7.5% from 2021 to 2026.
What are the major driving factors and opportunities in the biosensors market?
The emergence of nanotechnology-based biosensors, significant technological advancements in the last few years, increasing use of biosensors to monitor glucose levels in individuals with diabetes, surging demand for home-based point of care devices due to the COVID-19 pandemic, and rising government initiatives toward diagnostics are driving the growth of the biosensors market.
Who are the leading players in the global biosensors market?
Companies such as Abbott (US), Roche (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), and DuPont (US), are the leading players in the market. Moreover, these companies rely on strategies which includes new product launches and developments, partnership and collaborations, and acquisitions. Such advantages give these companies an edge over other companies in the market.
What is the COVID-19 impact on the biosensors market?
According to discussions with various primaries, the impact of COVID-19 on the biosensors market has been considered to be for the short-to-medium term; hence, it has been assumed that the impact of COVID-19 prevails from the first quarter of 2020 to its fourth quarter.
What are some of the technological advancements in the market?
Significant efforts have been made in the last few years for advancing biosensors technology and its applications. For instance, the multianalyte determination for environmental monitoring and screening is among the advancements that have been witnessed in the biosensor’s ecosystem. Miniaturization has helped develop small, compact, easy-to-handle biosensors, which has changed the conventional testing scenario in the medical and healthcare sectors. A few examples include compact blood glucose monitoring systems, cholesterol testing systems, and pregnancy testing systems. POC diagnostics—another technological advancement—contribute to the overall demand for biosensors. Players in the POC diagnostics market are increasingly focusing on technological advancements and new product developments. Product innovations and product launches are mainly focused on the development of technologically advanced, faster, and easy-to-use devices. Prevalent chronic diseases and conditions, such as heart diseases, stroke, cancer, type 2 diabetes, obesity, and arthritis, are among the most common, costly, and preventable of all health problems that are influencing consumers to adopt biosensors for the regular detection of pathogenic activities. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 27)
1.1 STUDY OBJECTIVES
1.2 DEFINITION AND SCOPE
1.3 STUDY SCOPE
FIGURE 1 BIOSENSORS MARKET SEGMENTATION
1.3.1 GEOGRAPHIC SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.4 YEARS CONSIDERED
1.5 CURRENCY
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 31)
2.1 RESEARCH DATA
FIGURE 2 BIOSENSORS MARKET: PROCESS FLOW OF MARKET SIZE ESTIMATION
FIGURE 3 BIOSENSORS MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key industry insights
2.1.2.2 Breakdown of primaries
2.1.2.3 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: SUPPLY-SIDE ANALYSIS
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 2 (SUPPLY SIDE) – IDENTIFICATION OF REVENUES GENERATED BY COMPANIES FROM MICRO SERVER OFFERINGS
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach for arriving at market size using bottom-up analysis (demand side)
FIGURE 6 MARKET: BOTTOM-UP APPROACH
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR ESTIMATING SIZE OF BIOSENSORS MARKET
2.2.2 TOP-DOWN APPROACH
2.2.2.1 Approach for arriving at market size using top-down analysis (supply side)
FIGURE 8 MARKET: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
TABLE 1 STUDY ASSUMPTIONS
2.5 LIMITATIONS
FIGURE 10 LIMITATIONS OF STUDY
3 EXECUTIVE SUMMARY (Page No. - 44)
FIGURE 11 MARKET FOR SENSOR PATCH IS EXPECTED TO GROW AT HIGHER RATE DURING FORECAST PERIOD
FIGURE 12 MARKET FOR WEARABLE BIOSENSORS IS EXPECTED TO GROW AT HIGHER RATE DURING FORECAST PERIOD
FIGURE 13 MARKET FOR ELECTROCHEMICAL TECHNOLOGY TO HOLD LARGEST SHARE IN 2026
FIGURE 14 POINT OF CARE APPLICATIONS HELD LARGEST SHARE OF MARKET IN 2021
FIGURE 15 BIOSENSORS MARKET IN APAC TO GROW AT HIGHEST CAGR FROM 2021 TO 2026
4 PREMIUM INSIGHTS (Page No. - 50)
4.1 ATTRACTIVE OPPORTUNITIES IN BIOSENSORS MARKET
FIGURE 16 RISING DEMAND FOR WEARABLE DEVICES ACROSS VARIOUS COUNTRIES TO IMPLEMENT MORE BIOSENSORS ACROSS POC AND HOME DIAGNOSTIC APPLICATIONS
4.2 MARKET IN NORTH AMERICA, BY COUNTRY AND BY PRODUCT
FIGURE 17 US AND NON-WEARABLE DEVICES ARE EXPECTED TO HOLD LARGEST SHARE OF NORTH AMERICAN BIOSENSORS MARKET IN 2021
4.3 MARKET IN APAC, BY APPLICATION
FIGURE 18 POC APPLICATION TO HOLD LARGEST SHARE OF MARKET IN APAC DURING FORECAST PERIOD
4.4 MARKET, BY COUNTRY
FIGURE 19 MARKET IN CHINA TO GROW AT HIGHEST CAGR FROM 2021 TO 2026
5 MARKET OVERVIEW (Page No. - 53)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 INCREASED DEMAND FOR HOME-BASED POC DEVICES DUE TO COVID-19 PANDEMIC TO DRIVE MARKET FOR BIOSENSORS
FIGURE 21 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MARKET
5.2.1 DRIVERS
5.2.1.1 Emergence of nanotechnology-based biosensors
5.2.1.2 Significant technological advancements in last few years
5.2.1.3 Increasing use of biosensors to monitor glucose levels in individuals with diabetes
5.2.1.4 Surging demand for home-based point-of-care devices due to COVID-19 pandemic
5.2.1.5 Rising government initiatives toward diagnostics
5.2.2 RESTRAINTS
5.2.2.1 Slow rate of commercialization and reluctance in adopting new treatment practices
5.2.2.2 High costs involved in R&D
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging market in developing countries
5.2.3.2 High-growth opportunities in food industry and environmental monitoring applications
5.2.3.3 High-growth opportunities in wearable device market
5.2.4 CHALLENGES
5.2.4.1 Government regulations—long certification and approval cycles
5.2.4.2 Pricing pressure in POC market
5.3 VALUE CHAIN ANALYSIS
FIGURE 22 BIOSENSOR MANUFACTURERS CONTRIBUTE MAJOR VALUE TO OVERALL COST OF BIOSENSORS
5.4 BIOSENSORS ECOSYSTEM
FIGURE 23 BIOSENSORS MARKET ECOSYSTEM
TABLE 2 SUPPLY CHAIN
5.5 PORTER’S FIVE FORCES ANALYSIS
TABLE 3 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.5.1 DEGREE OF COMPETITION
5.5.2 BARGAINING POWER OF SUPPLIERS
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 THREAT FROM SUBSTITUTES
5.5.5 THREAT FROM NEW ENTRANTS
5.6 CASE STUDIES FOR BIOSENSORS MARKET
5.6.1 I-STAT SYSTEM HELPS PATIENTS AT ROCHDALE URGENT CARE CENTER
5.6.2 INTEGRATED HEALTH SOLUTION PROVIDED COST SAVINGS AND INCREASED EFFICIENCY
5.6.3 REDUCING MATERNAL MORBIDITY AND MORTALITY THROUGH NON-INVASIVE HAEMOGLOBIN MONITORING
5.6.4 IMPROVING MOBILITY FOR PATIENTS AND REDUCING FALSE ALARMS FOR STAFF AT SUB-ACUTE CHILDREN’S HOSPITAL
5.6.5 ENABLING SEAMLESS DATA TRANSMISSION FROM PATIENT’S HOME
5.7 TECHNOLOGY ANALYSIS
5.8 AVERAGE SELLING PRICE (ASP) TREND ANALYSIS
FIGURE 24 AVERAGE SELLING PRICE OF BIOSENSORS, BY PRODUCT (USD)
5.9 TRADE ANALYSIS
TABLE 4 EXPORT SCENARIO FOR HS CODE: 901890, BY COUNTRY, 2015–2019 (USD THOUSAND)
TABLE 5 IMPORT SCENARIO FOR HS CODE: 901890, BY COUNTRY, 2015–2019 (USD THOUSAND)
5.10 PATENT ANALYSIS
5.11 STANDARDS AND REGULATIONS RELATED TO BIOSENSORS MARKET
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
FIGURE 25 REVENUE SHIFT FOR BIOSENSORS MARKET
6 BIOSENSORS MARKET, BY TYPE (Page No. - 74)
6.1 INTRODUCTION
FIGURE 26 MARKET FOR SENSOR PATCH IS EXPECTED TO GROW AT HIGHER RATE DURING FORECAST PERIOD
TABLE 6 MARKET, BY TYPE, 2017–2020 (USD BILLION)
TABLE 7 MARKET, BY TYPE, 2021–2026 (USD BILLION)
6.2 SENSOR PATCH
6.2.1 THESE DEVICES ASSIST PEOPLE IN SPECIALIZED PROFESSIONAL AND PERSONAL ACTIVITIES
FIGURE 27 MARKET FOR SENSOR PATCH IN NORTH AMERICA HOLDS LARGEST SHARE
TABLE 8 MARKET FOR SENSOR PATCH, BY REGION, 2017–2020 (USD MILLION)
TABLE 9 MARKET FOR SENSOR PATCH, BY REGION, 2021–2026 (USD MILLION)
6.3 EMBEDDED DEVICE
6.3.1 THEY DETECT BROAD SPECTRUM OF BIOLOGICAL ANALYTES AND SHOW GREATER RESPONSES AND SUCCESS RATES IN MEDICAL LABORATORIES AND FOOD BIOANALYSES
TABLE 10 MARKET FOR EMBEDDED DEVICE, BY REGION, 2017–2020 (USD BILLION)
TABLE 11MARKET FOR EMBEDDED DEVICE, BY REGION, 2021–2026 (USD BILLION)
7 BIOSENSORS MARKET, BY PRODUCT (Page No. - 79)
7.1 INTRODUCTION
FIGURE 28 MARKET FOR WEARABLE BIOSENSORS IS EXPECTED TO GROW AT HIGHER RATE DURING FORECAST PERIOD
TABLE 12 MARKET, BY PRODUCT, 2017–2020 (USD BILLION)
TABLE 13 MARKET, BY PRODUCT, 2021–2026 (USD BILLION)
TABLE 14 MARKET, BY PRODUCT, 2020–2026 (MILLION UNITS)
7.2 WEARABLE BIOSENSORS
FIGURE 29 WEARABLE MARKET IN APAC IS EXPECTED TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
TABLE 15 WEARABLE MARKET, BY REGION, 2017–2020 (USD BILLION)
TABLE 16 WEARABLE MARKET, BY REGION, 2021–2026 (USD BILLION)
TABLE 17 WEARABLE MARKET, BY TECHNOLOGY, 2017–2020 (USD BILLION)
TABLE 18 WEARABLE BIOSENSORS MARKET, BY TECHNOLOGY, 2021–2026 (USD BILLION)
7.2.1 WRISTWEAR
7.2.1.1 Offer real-time health and fitness tracking and monitoring
7.2.2 EYEWEAR
7.2.2.1 Smart glasses and smart lenses to have significant presence in market in coming years
7.2.3 FOOTWEAR
7.2.3.1 Help in monitoring kilometer run, calories burned, workout hours, blood pressure, and other fitness- and health-related data
7.2.4 NECKWEAR
7.2.4.1 Trendy devices that can help monitor fitness
7.2.5 BODYWEAR
7.2.5.1 Have potential to equip clothes used for daily wear with smart capabilities, making detection of body movements possible
7.2.6 OTHERS
TABLE 19 WEARABLE MARKET, BY PRODUCT, 2017–2020 (USD BILLION)
TABLE 20 WEARABLE MARKET, BY PRODUCT, 2021–2026 (USD BILLION)
7.3 NON-WEARABLE BIOSENSORS
7.3.1 OFFER REAL-TIME ON-SITE MONITORING OF PRODUCTION PROCESSES
TABLE 21 NON-WEARABLE MARKET, BY REGION, 2017–2020 (USD BILLION)
TABLE 22 MARKET, BY REGION, 2021–2026 (USD BILLION)
TABLE 23 NON-WEARABLE BIOSENSORS , BY TECHNOLOGY, 2017–2020 (USD BILLION)
TABLE 24 NON-WEARABLE BIOSENSORS , BY TECHNOLOGY, 2021–2026 (USD BILLION)
7.4 IMPACT OF COVID-19
8 BIOSENSORS MARKET, BY TECHNOLOGY (Page No. - 88)
8.1 INTRODUCTION
FIGURE 30 BIOSENSORS MARKET FOR ELECTROCHEMICAL TECHNOLOGY TO HOLD LARGEST SHARE IN 2026
TABLE 25 MARKET, BY TECHNOLOGY, 2017–2020 (USD BILLION)
TABLE 26 MARKET, BY TECHNOLOGY, 2021–2026 (USD BILLION)
8.2 ELECTROCHEMICAL BIOSENSORS
TABLE 27 BIOSENSORS MARKET FOR ELECTROCHEMICAL TECHNOLOGY, BY PRODUCT, 2017–2020 (USD BILLION)
TABLE 28 MARKET FOR ELECTROCHEMICAL TECHNOLOGY, BY PRODUCT, 2021–2026 (USD BILLION)
8.2.1 AMPEROMETRIC SENSORS
8.2.1.1 Blood glucose sensors
8.2.1.1.1 Suitable for medical devices for monitoring blood glucose
TABLE 29 GLUCOSE SENSORS AND DEVICES APPROVED BY FDA DURING 2019–2020
8.2.2 POTENTIOMETRIC SENSORS
8.2.2.1 Immunosensors
8.2.2.1.1 Enable label-free detection and quantification of immune complex
8.2.3 CONDUCTOMETRIC SENSORS
8.2.3.1 Conductometric devices can be used to study enzymatic reactions and for practical applications, including drug detection in human urine and pollutant detection in environmental testing
8.3 OPTICAL BIOSENSORS
FIGURE 31 OPTICAL TECHNOLOGY FOR WEARABLE DEVICES IS EXPECTED TO EXPERIENCE HIGHEST GROWTH RATE IN MARKET DURING FORECAST PERIOD
TABLE 30 MARKET FOR OPTICAL TECHNOLOGY, BY PRODUCT, 2017–2020 (USD BILLION)
TABLE 31 MARKET FOR OPTICAL TECHNOLOGY, BY PRODUCT, 2021–2026 (USD BILLION)
8.3.1 SPR
8.3.1.1 Measure interactions in real-time with high sensitivity and without needing labels
8.3.2 COLORIMETRIC BIOSENSORS
8.3.2.1 Used in various applications, such as detection and identification of virulence activities
8.3.3 FLUORESCENCE BIOSENSORS
8.3.3.1 Provide better sensitivities and specificities, as well as ease of labeling, while detection
8.4 PIEZOELECTRIC BIOSENSORS
TABLE 32 MARKET FOR PIEZOELECTRIC TECHNOLOGY, BY PRODUCT, 2017–2020 (USD BILLION)
TABLE 33 MARKET FOR PIEZOELECTRIC TECHNOLOGY, BY PRODUCT, 2021–2026 (USD BILLION)
8.4.1 ACOUSTIC BIOSENSORS
8.4.1.1 Monitor changes in physical properties of acoustic waves in response to measurand
8.4.2 MICROCANTILEVER BIOSENSORS
8.4.2.1 Promising tool for detecting biomolecular interactions with improved accuracy
8.5 THERMAL BIOSENSORS
8.5.1 DO NOT REQUIRE FREQUENT RECALIBRATION AND ARE INSENSITIVE TO OPTICAL AND ELECTROCHEMICAL PROPERTIES OF SAMPLE
TABLE 34 MARKET FOR THERMAL TECHNOLOGY, BY PRODUCT, 2017–2020 (USD BILLION)
TABLE 35 MARKET FOR THERMAL TECHNOLOGY, BY PRODUCT, 2021–2026 (USD BILLION)
8.6 NANOMECHANICAL BIOSENSORS
8.6.1 HAVE ABILITY TO PERFORM RAPID, SENSITIVE, AND SELECTIVE DETECTION OF BIOLOGICAL AND BIOCHEMICAL ENTITIES
TABLE 36 MARKET FOR NANOMECHANICAL TECHNOLOGY, BY PRODUCT, 2017–2020 (USD BILLION)
TABLE 37 BIOSENSOR MARKET FOR NANOMECHANICAL TECHNOLOGY, BY PRODUCT, 2021–2026 (USD BILLION)
9 BIOSENSORS MARKET, BY COMPONENT (Page No. - 100)
9.1 INTRODUCTION
9.2 BIORECEPTOR MOLECULES
9.2.1 PRESENTLY, ANTIBODIES AND PROTEINS ARE ALSO USED AS BIORECEPTOR MOLECULES IN BIOSENSORS
9.3 BIOLOGICAL ELEMENT
9.3.1 BIOLOGICAL ELEMENTS ARE MATERIALS RELATED TO BIOMOLECULES
9.4 TRANSDUCER
9.4.1 TRANSDUCER IS MOST IMPORTANT COMPONENT OF BIOSENSORS, IT COVERTS BIOCHEMICAL ACTIVITIES INTO ELECTRICAL SIGNALS
10 BIOSENSORS MARKET, BY APPLICATION (Page No. - 101)
10.1 INTRODUCTION
FIGURE 32 POINT OF CARE APPLICATIONS HELD LARGEST MARKET SHARE OF BIOSENSORS MARKET IN 2021
TABLE 38 MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 39 MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
10.2 POC
TABLE 40 MARKET FOR POC APPLICATION, BY TYPE, 2017–2020 (USD BILLION)
TABLE 41 MARKET FOR POC APPLICATION, BY TYPE, 2021–2026 (USD BILLION)
TABLE 42 BIOSENSOR MARKET FOR POC APPLICATION, BY REGION, 2017–2020 (USD BILLION)
TABLE 43 BIOSENSOR MARKET FOR POC APPLICATION, BY REGION, 2021–2026 (USD BILLION)
10.2.1 GLUCOSE MONITORING
10.2.1.1 Rising prevalence of diabetes worldwide, technological advancements in self-monitoring of blood glucose, and growing awareness about PoC testing
TABLE 44 BIOSENSOR MARKET FOR GLUCOSE MONITORING FOR POC APPLICATION, BY REGION, 2017–2020 (USD BILLION)
TABLE 45 MARKET FOR GLUCOSE MONITORING FOR POC APPLICATION, BY REGION, 2021–2026 (USD BILLION)
10.2.2 CARDIAC MARKER
10.2.2.1 Sedentary urban lifestyles causing increase in cardiovascular diseases
TABLE 46 MARKET FOR CARDIAC MARKER FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 47 MARKET FOR CARDIAC MARKER FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION)
10.2.3 INFECTIOUS DISEASE DETECTION
10.2.3.1 Detection of toxins, bacteria, and viruses in variety of physiological and environmental matrices
FIGURE 33 INFECTIOUS DISEASE DETECTION OF POC APPLICATION HOLDS LARGEST MARKET SHARE ACROSS NORTH AMERICA DURING FORECAST PERIOD
TABLE 48 MARKET FOR INFECTIOUS DISEASE DETECTION FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 49 MARKET FOR INFECTIOUS DISEASE DETECTION FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION)
10.2.4 COAGULATION MONITORING
10.2.4.1 Growing use of anticoagulant therapy, coupled with adoption of self-testing kits for use at home
TABLE 50 BIOSENSORS MARKET FOR COAGULATION MONITORING FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 51 MARKET FOR COAGULATION MONITORING FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION)
10.2.5 PREGNANCY TESTING
10.2.5.1 Growing preference of women for confidentiality and accessibility of test results
TABLE 52 MARKET FOR PREGNANCY TESTING FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 53 MARKET FOR PREGNANCY TESTING FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION)
10.2.6 BLOOD GAS & ELECTROLYTE DETECTION
10.2.6.1 Growing global aging population is significantly driving growth of market
TABLE 54 MARKET FOR BLOOD GAS & ELECTROLYTE DETECTION FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 55 MARKET FOR BLOOD GAS & ELECTROLYTE DETECTION FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION)
10.2.7 DETECTION OF TUMOR OR CANCER MARKER
10.2.7.1 Increasing number of people suffering from cancer and growth in investments in cancer research
TABLE 56 MARKET FOR TUMOR OR CANCER MARKER FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 57 MARKET FOR TUMOR OR CANCER MARKER FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION)
10.2.8 URINALYSIS TESTING
10.2.8.1 Rising number of urinary tract infections among individuals
TABLE 58 MARKET FOR URINALYSIS TESTING FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 59 MARKET FOR URINALYSIS TESTING FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION)
10.2.9 CHOLESTEROL TESTING
10.2.9.1 Increasing prevalence of CVDs due to aging and obese population
TABLE 60 MARKET FOR CHOLESTEROL TESTING FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 61 MARKET FOR CHOLESTEROL TESTING FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION)
10.3 HOME DIAGNOSTICS
TABLE 62 MARKET FOR HOME DIAGNOSTICS APPLICATION, BY TYPE, 2017–2020 (USD MILLION)
TABLE 63 MARKET FOR HOME DIAGNOSTICS APPLICATION, BY TYPE, 2021–2026 (USD MILLION)
FIGURE 34 MARKET FOR HOME DIAGNOSTIC APPLICATIONS IN APAC IS EXPECTED TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
TABLE 64 MARKET FOR HOME DIAGNOSTICS APPLICATION, BY REGION. 2017–2020 (USD BILLION)
TABLE 65 MARKET FOR HOME DIAGNOSTICS APPLICATION, BY REGION, 2021–2026 (USD BILLION)
10.3.1 GLUCOSE MONITORING
10.3.1.1 Growing preference for self-monitoring blood glucose devices
TABLE 66 MARKET FOR GLUCOSE MONITORING FOR HOME DIAGNOSTICS APPLICATION, BY REGION, 2017–2020 (USD BILLION)
TABLE 67 MARKET FOR GLUCOSE MONITORING FOR HOME DIAGNOSTICS APPLICATION, BY REGION, 2021–2026 (USD BILLION)
10.3.2 PREGNANCY TESTING
10.3.2.1 Need for portable and user-friendly pregnancy testing devices
TABLE 68 MARKET FOR PREGNANCY TESTING FOR HOME DIAGNOSTIC APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 69 MARKET FOR PREGNANCY TESTING FOR HOME DIAGNOSTIC APPLICATION, BY REGION, 2021–2026 (USD MILLION)
10.3.3 CHOLESTEROL TESTING
10.3.3.1 Growth of diseases due to increased cholesterol levels in individuals
TABLE 70 MARKET FOR CHOLESTEROL TESTING FOR HOME DIAGNOSTICS APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 71 MARKET FOR CHOLESTEROL TESTING FOR HOME DIAGNOSTICS APPLICATION, BY REGION, 2021–2026 (USD MILLION)
10.4 RESEARCH LABS
10.4.1 NEED FOR BIOSENSOR-BASED PRODUCT DEVELOPMENT FOR EARLY MONITORING OF DISEASES
TABLE 72 MARKET FOR RESEARCH LAB APPLICATION, BY REGION, 2017–2020 (USD BILLION)
TABLE 73 MARKET FOR RESEARCH LAB APPLICATION, BY REGION, 2021–2026 (USD BILLION)
10.5 ENVIRONMENTAL MONITORING
10.5.1 DETECTION OF CONTAMINANTS IN COMPLEX MATRICES WITH SEVERAL ADVANTAGES TO ENHANCE MARKET GROWTH
TABLE 74 MARKET FOR ENVIRONMENTAL MONITORING APPLICATION, BY REGION, 2017–2020 (USD BILLION)
TABLE 75 MARKET FOR ENVIRONMENTAL MONITORING APPLICATION, BY REGION, 2021–2026 (USD BILLION)
10.6 FOOD & BEVERAGES
10.6.1 BIOSENSORS ARE USED FOR PATHOGEN DETECTION AND ARE HELPING TO MEET STRINGENT FOOD STANDARDS
TABLE 76 MARKET FOR FOOD & BEVERAGES APPLICATION, BY REGION, 2017–2020 (USD BILLION)
TABLE 77 MARKET FOR FOOD & BEVERAGES APPLICATION, BY REGION, 2021–2026 (USD BILLION)
10.7 BIODEFENSE
10.7.1 USE OF BIOSENSORS TO DETECT MICROBIAL PATHOGENS DURING BIOLOGICAL WARFARE
TABLE 78 MARKET FOR BIODEFENSE APPLICATION, BY REGION, 2017–2020 (USD MILLION)
TABLE 79 MARKET FOR BIODEFENSE APPLICATION, BY REGION, 2021–2026 (USD MILLION)
11 GEOGRAPHIC ANALYSIS (Page No. - 124)
11.1 INTRODUCTION
FIGURE 35 NORTH AMERICA HOLDS LARGEST SHARE OF BIOSENSORS MARKET
TABLE 80 MARKET BY REGION, 2017–2020 (USD BILLION)
TABLE 81 MARKET BY REGION, 2021–2026 (USD BILLION)
11.2 NORTH AMERICA
FIGURE 36 SNAPSHOT: BIOSENSORS MARKET IN NORTH AMERICA
TABLE 82 MARKET IN NORTH AMERICA, BY APPLICATION, 2017–2020 (USD BILLION)
TABLE 83 MARKET IN NORTH AMERICA, BY APPLICATION, 2021–2026 (USD BILLION)
TABLE 84 MARKET IN NORTH AMERICA, BY POC APPLICATION, 2017–2020 (USD BILLION)
TABLE 85 MARKET IN NORTH AMERICA, BY POC APPLICATION, 2021–2026 (USD BILLION)
TABLE 86 MARKET IN NORTH AMERICA, BY HOME DIAGNOSTICS APPLICATION, 2017–2020 (USD MILLION)
TABLE 87 MARKET IN NORTH AMERICA, BY HOME DIAGNOSTICS APPLICATION, 2021–2026 (USD MILLION)
TABLE 88 MARKET FOR NORTH AMERICA, BY TYPE, 2017–2020 (USD BILLION)
TABLE 89 MARKET FOR NORTH AMERICA, BY TYPE, 2021–2026 (USD BILLION)
TABLE 90 MARKET FOR NORTH AMERICA, BY PRODUCT, 2017–2020 (USD BILLION)
TABLE 91 MARKET FOR NORTH AMERICA, BY PRODUCT, 2021–2026 (USD BILLION)
FIGURE 37 US HOLDS LARGEST SHARE OF BIOSENSORS MARKET
TABLE 92 MARKET IN NORTH AMERICA, BY COUNTRY, 2017–2020 (USD BILLION)
TABLE 93 MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2026 (USD BILLION)
11.2.1 US
11.2.1.1 Presence of key players that offer biosensor-based PoC applications in US
11.2.2 CANADA
11.2.2.1 Increasing government support likely to escalate growth of biosensors market in Canada
11.2.3 MEXICO
11.2.3.1 Use of biosensors to detect cardiovascular disorders propels market growth in Mexico
11.3 EUROPE
FIGURE 38 SNAPSHOT: BIOSENSOR MARKET IN EUROPE
TABLE 94 MARKET IN EUROPE, BY APPLICATION, 2017–2020 (USD BILLION)
TABLE 95 MARKET IN EUROPE, BY APPLICATION, 2021–2026 (USD BILLION)
TABLE 96 MARKET IN EUROPE, BY POC APPLICATION, 2017–2020 (USD MILLION)
TABLE 97 MARKET IN EUROPE, BY POC APPLICATION, 2021–2026 (USD MILLION)
TABLE 98 MARKET IN EUROPE, BY HOME DIAGNOSTICS APPLICATION, 2017–2020 (USD MILLION)
TABLE 99 MARKET IN EUROPE, BY HOME DIAGNOSTICS APPLICATION, 2021–2026 (USD MILLION)
TABLE 100MARKET IN EUROPE, BY TYPE, 2017–2020 (USD BILLION)
TABLE 101 MARKET IN EUROPE, BY TYPE, 2021–2026 (USD BILLION)
TABLE 102 MARKET IN EUROPE, BY PRODUCT, 2017–2020 (USD BILLION)
TABLE 103 MARKET IN EUROPE, BY PRODUCT, 2021–2026 (USD BILLION)
TABLE 104 MARKET IN EUROPE, BY COUNTRY, 2017–2020 (USD BILLION)
TABLE 105 MARKET IN EUROPE, BY COUNTRY, 2021–2026 (USD BILLION)
11.3.1 GERMANY
11.3.1.1 Monitoring of chronic diseases to escalate biosensors market growth
11.3.2 FRANCE
11.3.2.1 Technological advancements in healthcare systems drive growth of market in France
11.3.3 UK
11.3.3.1 Rising cardiac diseases and aging population are factors driving market growth in UK
11.3.4 ITALY
11.3.4.1 Growing private sector results in increasing demand for biosensors for various applications
11.3.5 REST OF EUROPE
11.4 APAC
FIGURE 39 SNAPSHOT OF BIOSENSORS MARKET IN APAC
TABLE 106 MARKET IN APAC, BY APPLICATION, 2017–2020 (USD BILLION)
TABLE 107 MARKET IN APAC, BY APPLICATION, 2021–2026 (USD BILLION)
TABLE 10MARKET IN APAC, BY POC APPLICATION, 2017–2020 (USD MILLION)
TABLE 109 MARKET IN APAC, BY POC APPLICATION, 2021–2026 (USD MILLION)
TABLE 110 MARKET IN APAC, BY HOME DIAGNOSTICS APPLICATION, 2017–2020 (USD MILLION)
TABLE 111 MARKET IN APAC, BY HOME DIAGNOSTICS APPLICATION, 2021–2026 (USD MILLION)
TABLE 112 MARKET IN APAC, BY TYPE, 2017–2020 (USD BILLION)
TABLE 113 MARKET IN APAC, BY TYPE, 2021–2026 (USD BILLION)
TABLE 114 MARKET IN APAC, BY PRODUCT, 2017–2020 (USD BILLION)
TABLE 115 BIOSENSOR MARKET IN APAC, BY PRODUCT, 2021–2026 (USD BILLION)
FIGURE 40 BIOSENSOR MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
TABLE 116 BIOSENSORS MARKET IN APAC, BY COUNTRY, 2017–2020 (USD BILLION)
TABLE 117 BIOSENSOR MARKET IN APAC, BY COUNTRY, 2021–2026 (USD BILLION)
11.4.1 CHINA
11.4.1.1 Government initiatives toward creating better healthcare products and services likely to propel biosensors market growth in China
11.4.2 JAPAN
11.4.2.1 Increase in standard of living, rise in health awareness, and surge in aging population are key factors driving growth of biosensors market in Japan
11.4.3 INDIA
11.4.3.1 Growing population in India escalates demand for biosensors for healthcare services
11.4.4 REST OF APAC
11.5 ROW
TABLE 118 MARKET IN ROW, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 119 MARKET IN ROW, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 120 MARKET IN ROW, BY POC APPLICATION, 2017–2020 (USD MILLION)
TABLE 121 MARKET IN ROW, BY POC APPLICATION, 2021–2026 (USD MILLION)
TABLE 122 MARKET IN ROW, BY HOME DIAGNOSTICS APPLICATION, 2017–2020 (USD MILLION)
TABLE 123 MARKET IN ROW, BY HOME DIAGNOSTICS APPLICATION, 2021–2026 (USD MILLION)
TABLE 124 MARKET IN ROW, BY TYPE, 2017–2020 (USD BILLION)
TABLE 125 MARKET IN ROW, BY TYPE, 2021–2026 (USD BILLION)
TABLE 126 MARKET IN ROW, BY PRODUCT, 2017–2020 (USD BILLION)
TABLE 127 MARKET IN ROW, BY PRODUCT, 2021–2026 (USD BILLION)
TABLE 128 MARKET IN ROW, BY COUNTRY, 2017–2020 (USD BILLION)
TABLE 129 MARKET IN ROW, BY COUNTRY, 2021–2026 (USD BILLION)
11.5.1 SOUTH AMERICA
11.5.1.1 Growing environment-related concerns have boosted adoption of biosensors for environmental monitoring applications in South America
11.5.2 MIDDLE EAST AND AFRICA
11.5.2.1 Significant government support and financial support from global firms for adoption of POC testing kits will drive market for biosensors across Middle East and Africa
11.6 IMPACT OF COVID-19
12 COMPETITIVE LANDSCAPE (Page No. - 152)
12.1 OVERVIEW
12.2 MARKET EVALUATION FRAMEWORK
TABLE 130 OVERVIEW OF STRATEGIES DEPLOYED BY KEY BIOSENSORS PLAYERS
12.2.1 PRODUCT PORTFOLIO
12.2.2 REGIONAL FOCUS
12.2.3 MANUFACTURING FOOTPRINT
12.2.4 ORGANIC/INORGANIC GROWTH STRATEGIES
12.3 REVENUE ANALYSIS OF LEADING PLAYERS (2016–2020)
FIGURE 41 FIVE YEAR REVENUE ANALYSIS OF TOP 5 PLAYERS IN BIOSENSORS MARKET
12.4 MARKET SHARE ANALYSIS: BIOSENSORS MARKET, 2020
TABLE 131 DEGREE OF COMPETITION
12.5 COMPANY EVALUATION MATRIX
12.5.1 STAR
12.5.2 EMERGING LEADER
12.5.3 PERVASIVE
12.5.4 PARTICIPANT
FIGURE 42 COMPANY EVALUATION MATRIX, 2020
12.6 STARTUP EVALUATION MATRIX
TABLE 132 LIST OF STARTUP COMPANIES IN BIOSENSORS MARKET
12.6.1 PROGRESSIVE COMPANY
12.6.2 RESPONSIVE COMPANY
12.6.3 DYNAMIC COMPANY
12.6.4 STARTING BLOCK
FIGURE 43 STARTUP (SME) EVALUATION MATRIX, 2020
12.7 COMPANY PRODUCT FOOTPRINT
TABLE 133 COMPANY PRODUCT FOOTPRINT
TABLE 134 FOOTPRINT OF DIFFERENT SENSOR TYPES BY DIFFERENT COMPANIES
TABLE 135 FOOTPRINT OF DIFFERENT COMPANIES ACROSS DIFFERENT APPLICATIONS
TABLE 136 REGIONAL FOOTPRINT OF DIFFERENT COMPANIES
12.8 COMPETITIVE SITUATIONS AND TRENDS
12.8.1 PRODUCT LAUNCHES AND DEVELOPMENTS
TABLE 137 PRODUCT LAUNCHES AND DEVELOPMENTS, 2020
12.8.2 DEALS
TABLE 138 DEALS, 2019–2021
13 COMPANY PROFILES (Page No. - 169)
(Business Overview, Products Offered, Recent Developments, COVID-19 related developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1 KEY PLAYERS
13.1.1 ABBOTT
TABLE 139 ABBOTT: BUSINESS OVERVIEW
FIGURE 44 ABBOTT: COMPANY SNAPSHOT
13.1.2 ROCHE
TABLE 140 ROCHE: BUSINESS OVERVIEW
FIGURE 45 ROCHE: COMPANY SNAPSHOT
13.1.3 MEDTRONIC
TABLE 141 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 46 MEDTRONIC: COMPANY SNAPSHOT
13.1.4 BIO-RAD LABORATORIES
TABLE 142 BIO-RAD LABORATORIES: BUSINESS OVERVIEW
FIGURE 47 BIO-RAD LABORATORIES: COMPANY SNAPSHOT
13.1.5 DUPONT
TABLE 143 DUPONT: BUSINESS OVERVIEW
FIGURE 48 DUPONT: COMPANY SNAPSHOT
13.1.6 BIOSENSORS INTERNATIONAL GROUP
TABLE 144 BIOSENSORS INTERNATIONAL GROUP: BUSINESS OVERVIEW
13.1.7 CYTIVA
TABLE 145 CYTIVA: BUSINESS OVERVIEW
13.1.8 DEXCOM
TABLE 146 DEXCOM: BUSINESS OVERVIEW
FIGURE 49 DEXCOM: COMPANY SNAPSHOT
13.1.9 LIFESCAN
TABLE 147 LIFESCAN: BUSINESS OVERVIEW
13.1.10 MASIMO
TABLE 148 MASIMO: BUSINESS OVERVIEW
FIGURE 50 MASIMO: COMPANY SNAPSHOT
13.1.11 NOVA BIOMEDICAL
TABLE 149 NOVA BIOMEDICAL: BUSINESS OVERVIEW
13.1.12 UNIVERSAL BIOSENSORS
TABLE 150 UNIVERSAL BIOSENSORS: BUSINESS OVERVIEW
FIGURE 51 UNIVERSAL BIOSENSORS: COMPANY SNAPSHOT
13.2 OTHER KEY PLAYERS
13.2.1 ACON LABORATORIES
13.2.2 CARDEA BIO
13.2.3 CONDUCTIVE TECHNOLOGIES
13.2.4 EARLYSENSE
13.2.5 EASTPRINT INCORPORATED
13.2.6 IST AG
13.2.7 LIFESIGNALS
13.2.8 NEUROSKY
13.2.9 PINNACLE TECHNOLOGY
13.2.10 SD BIOSENSOR
13.2.11 VITALCONNECT
13.2.12 XSENSIO
13.2.13 ZIMMER AND PEACOCK
*Details on Business Overview, Products Offered, Recent Developments, COVID-19 related developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX (Page No. - 222)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
The study involved four major activities in estimating the biosensors market. Secondary and primary sources have been used to identify and collect information for an extensive technical and commercial study of the biosensors market. Validating findings, assumptions, and sizing with industry experts across the value chain through primary research has been the next step. Both top-down and bottom-up approaches have been employed to estimate the complete market size. After that, market breakdown and data triangulation methods have been used to estimate the market size of segments and subsegments. This research includes the study of annual reports of the market players to identify the top players, along with interviews of the key opinion leaders such as chief executive officers (CEOs), directors, and marketing personnel.
Secondary Research
In the secondary research process, various secondary sources were referred for identifying and collecting information for this study. The secondary sources include annual reports, press releases, and investor presentations of companies; white papers, journals and certified publications, and articles from recognized authors; and websites, directories, and databases. Secondary research has mainly been used to obtain key information about the industry’s supply chain, the market’s value chain, major players, market classification, and segmentation according to the industry trends to the bottommost level, geographic markets, and key developments from both markets- and technology-oriented perspectives. The secondary data has been collected and analyzed to arrive at the overall market size, which has further been validated by primary research. A few important secondary sources referred to for this research study are International Diabetes Federation (IDF), American Diabetes Association (ADA), and National Biodefense Analysis and Countermeasures Center (NBACC).
Primary Research
Extensive primary research has been conducted after acquiring knowledge about the biosensors market scenario through secondary research. Several primary interviews have been conducted with market experts from both supply (biosensor manufacturers) and demand (biosensor applications) sides across four major regions—North America, Europe, APAC, and RoW (including South America, the Middle East, and Africa). Approximately 30% of the primary interviews have been conducted with the demand side and 70% with the supply side. Primary data has been mainly collected through telephonic interviews, which consist of approximately 80% of the overall primary interviews. Moreover, questionnaires and emails have also been used to collect the data.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
In the complete market engineering process, both top-down and bottom-up approaches have been used along with several data triangulation methods to perform the market estimation and forecasting for the overall market segments and subsegments listed in this report. The key players in the market have been identified through secondary research, and their market shares in the respective regions have been determined through primary and secondary research. The entire procedure includes the study of annual and financial reports of top market players and extensive interviews for key insights from industry experts, such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources. All the possible parameters affecting the markets covered in this research study have been accounted for, viewed in detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data has been consolidated and supplemented with detailed inputs and analysis from MarketsandMarkets and presented in this report.
The bottom-up approach has been used to arrive at the overall size of the biosensors market from revenues of the key players and their shares in the market. The overall market size has been calculated based on the revenues of the key players identified in the market. The research methodology used to estimate the market size by the bottom-up approach includes the following:
- Identifying key participants that influence the overall biosensors market, along with related component providers
- Analyzing key providers of biosensors and biosensor components, along with raw material providers and studying their portfolios to understand the different components and products offered by them in addition to examining the developments undertaken by the key players during the pre-COVID-19 period, as well as studying the measures/steps undertaken by them to deal with COVID-19
- Predicting the anticipated change in demand for biosensors and their components in the post-COVID-19 scenario
- Analyzing trends pertaining to the use of biosensors in different applications such as point of care, home diagnostics, research lab, food & beverages, environmental monitoring, and biodefense.
- Tracking the ongoing and identifying the upcoming developments in the market in the form of investments, R&D activities, product launches, collaborations, and partnerships, and forecasting the market based on these developments and other critical parameters
- Carrying out multiple discussions with key opinion leaders to understand the various types of biosensors used in different applications and recent trends in the market, thereby analyzing the breakup of the scope of the work carried out by the leading companies
- Arriving at the market estimates by analyzing the revenues generated by companies and combining the same to get the market estimates
- Segmenting the overall market into different segments
- Verifying and crosschecking estimates at every level through discussions with key opinion leaders such as CXOs, directors, and operations managers, and finally with the domain experts at MarketsandMarkets
- Studying various paid and unpaid sources of information such as annual reports, press releases, white papers, and databases
In the top-down approach, the overall market size has been used to estimate the size of the individual markets (mentioned in the market segmentation) through percentage splits obtained from secondary and primary research. For the calculation of the sizes of specific market segments, the size of the most appropriate parent market has been considered to implement the top-down approach. Data from interviews have been consolidated, checked for consistency and accuracy, and inserted into a data model to arrive at the market numbers following the top-down approach. The market size in different regions has been identified and analyzed through secondary research.
Upon the estimation and validation of the size of the biosensors market, further segmentation has been carried out based on consolidated inputs from key players with respect to regional adoption trends of biosensors and pervasiveness of the different types of biosensors across different applications and regions.
The research methodology used to estimate the market size by the top-down approach includes the following:
- Focusing on top-line investments and expenditures made in the biosensors market ecosystem
- Calculating the market size considering revenues generated by the key players through the sales of biosensors and components; estimating the market size for 2020 by considering the impact of COVID-19 across the value chain of the biosensors market, and analyzing recovery scenarios across the world to further forecast the market size
- Conducting multiple on-field discussions with key opinion leaders of key companies operating in the biosensors market to understand the pre-COVID-19 and post-COVID-19 scenarios
- Estimating the geographic split using secondary sources based on various factors such as the demand for biosensors in a specific country and region, adoption rate across different products such as wearables and non-wearable biosensors for applications such as point of care, home diagnostics, research lab, food & beverages, environmental monitoring, and biodefense.
Data Triangulation
After arriving at the overall market size from the estimation process explained earlier, the overall market is split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all the segments and subsegments, the market breakdown and data triangulation procedures are employed, wherever applicable. The data is triangulated by studying various factors and trends from both the demand and supply sides. Along with this, the market size is validated using both top-down and bottom-up approaches.
Report Objectives
- To describe and forecast the biosensors market, in terms of value, by type, product, technology, and application
- To describe and forecast the biosensors market, in terms of value, by region—North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
- To provide detailed information regarding major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To strategically analyze the micro markets with respect to individual growth trends, prospects, and contributions to the overall biosensors market
- To analyze opportunities for stakeholders in the biosensors market by identifying the high-growth segments
- To profile key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing the competitive landscape for market leaders
- To analyze competitive developments such as mergers and acquisitions, expansions, product and service launches, partnerships, contracts, and agreements in the biosensors market
Available Customizations
With the given market data, MarketsandMarkets offers customizations according to the specific requirements of companies. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players
Get in-depth analysis of the COVID-19 impact on the Biosensors Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Biosensors Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Biosensors Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Biosensors Market